Does Cigna Cover ADHD Treatment in Maine? A 2026 Guide

Last updated: July 20, 2026

If you have Cigna health insurance and live in Maine, you may be wondering whether your plan helps cover ADHD diagnosis and treatment. Including evaluation, therapy, and prescription medication. The short answer: Cigna plans may cover ADHD treatment, but the path to benefits involves navigating Maine’s mental health parity law, Cigna’s 2026 prior authorization policy for all ADHD stimulants, and Maine’s broad electronic prescribing requirements. This guide walks through what you need to know before you book an appointment.

Quick facts for Maine Cigna members:

• Insurer: Cigna Health and Life Insurance Company
• Pharmacy Benefit Manager (PBM): Express Scripts (ESI)
• Maine parity law: Me. Rev. Stat. Ann. tit. 24-A, § 2749-A (applies to ADHD as a mental health condition)
• Cigna PA policy IP0477 (eff. May 15, 2026): All ADHD stimulants. Generic and brand. Require prior authorization
• Maine EPCS: Schedule II stimulants (Adderall, Ritalin, Vyvanse, Concerta, etc.) require electronic prescribing under Maine law (Schedule II. V mandate)
• Non-stimulants (Strattera, Qelbree, Intuniv, Kapvay): Non-scheduled. Maine EPCS requirement does not apply
• Cigna member services: 1-800-244-6224
• ESI pharmacy help: 1-800-835-3784
• Maine Bureau of Insurance: 1-800-300-5000

See if Cigna may cover your ADHD treatment at Klarity Health →

Does Cigna Cover ADHD Treatment in Maine?

Cigna’s commercial fully-insured plans sold in Maine are required under state and federal law to cover ADHD treatment on terms no more restrictive than coverage for comparable medical or surgical conditions. This is the core requirement of Maine’s mental health parity statute (Me. Rev. Stat. Ann. tit. 24-A, § 2749-A) and the federal Mental Health Parity and Addiction Equity Act (MHPAEA).

In practice, this means Cigna may cover:

• ADHD diagnostic evaluations (psychological or psychiatric)
• Outpatient therapy (individual, group, or behavioral)
• Telehealth ADHD consultations
• ADHD medications. Stimulant and non-stimulant. Via Express Scripts
• Ongoing medication management visits

Important caveat: Coverage varies significantly by plan type, employer group contract, and whether your plan is fully insured (state-regulated) or self-funded (governed by federal ERISA, not Maine state law). Always verify your specific benefits before scheduling.

Maine Mental Health Parity Law: What § 2749-A Means for ADHD Coverage

Maine’s mental health parity statute. Me. Rev. Stat. Ann. tit. 24-A, § 2749-A. Requires that commercial fully-insured health plans cover mental health and substance use disorder (MH/SUD) benefits on terms no more restrictive than the most generous medical or surgical benefits offered under the same plan. ADHD (attention-deficit/hyperactivity disorder) is classified as a mental health condition and falls squarely within § 2749-A’s scope.

What parity means in practice for Cigna members:

• Quantitative limits: Cigna cannot cap the number of ADHD therapy visits or medication refills at a level lower than comparable medical visit limits. Unless it applies the same limit to medical/surgical benefits.
• Non-quantitative treatment limits (NQTLs): Prior authorization, step therapy, and formulary tier requirements for ADHD medications must be no more burdensome than equivalent requirements applied to comparable medical conditions.
• Parity complaints: If you believe Cigna has applied a more restrictive standard to your ADHD treatment than to a comparable medical benefit, you may file a parity complaint with the Maine Bureau of Insurance (1-800-300-5000).

Self-funded plans: If your employer self-funds its health plan, Maine § 2749-A does not apply. Federal MHPAEA governs instead. Contact the U.S. Department of Labor’s Employee Benefits Security Administration (EBSA) at 1-866-444-3272 for federal parity complaints.

Maine Electronic Prescribing (EPCS) Requirements for ADHD Medications

Maine has one of the broadest electronic prescribing mandates in the country. Under Maine law, controlled substances in Schedules II through V must generally be prescribed electronically. For ADHD patients, this has significant practical implications.

What this means for telehealth patients: If you see an ADHD provider via telehealth (including through Klarity Health), your provider must use a DEA-compliant EPCS platform to send Schedule II prescriptions to your Maine pharmacy. Most modern telehealth platforms, including Klarity’s, are EPCS-capable. Confirm this before booking if Schedule II stimulants are a priority for you.

Cigna PA Policy IP0477: All ADHD Stimulants Now Require Prior Authorization

One of the most significant changes for Cigna members in 2026 is the rollout of policy IP0477, effective May 15, 2026. Under IP0477, all ADHD stimulant medications. Including generic formulations. Now require prior authorization under Cigna plans using Express Scripts.

This is a notable shift from prior years when many generic stimulants (such as generic amphetamine salts, generic methylphenidate) could be dispensed without PA. As of May 15, 2026, no stimulant ADHD medication bypasses the PA process under Cigna/ESI.

What IP0477 typically requires for PA approval:

• Confirmed ADHD diagnosis from a licensed provider (psychiatrist, physician, APRN, or PA)
• Documentation of symptom severity and functional impairment
• For brand stimulants: evidence of trial or contraindication to a preferred generic
• Prescriber attestation of medical necessity
• Compliance with Maine EPCS for Schedule II medications

PA turnaround times under Maine law: For non-urgent PA requests, Cigna must respond within 2 business days (standard) or 1 business day (urgent). For urgent/concurrent requests, 72 hours maximum. If Cigna misses these deadlines, the request is deemed approved under Maine law.

Express Scripts ADHD Formulary for Cigna Maine Plans (2026)

Formulary tiers and PA requirements may vary by specific Cigna plan. Always verify with ESI at 1-800-835-3784 or through the Cigna member portal before filling a prescription.

How to Get Prior Authorization for ADHD Medication Through Cigna in Maine

1. Your provider submits the PA request. PA requests must come from your licensed prescribing provider, not from you directly. Your provider submits clinical documentation. Diagnosis, severity, functional impairment, and medication rationale. To Cigna or ESI.
2. Cigna reviews the request. Under Maine law and IP0477 criteria, Cigna must respond within 2 business days (standard) or 1 business day (urgent). Failure to respond within the required window is a deemed approval.
3. If approved: Your prescription is authorized. Because most ADHD stimulants are Schedule II, your provider must transmit the prescription electronically under Maine’s EPCS mandate.
4. If denied: Cigna must send a written denial with the specific reason. You have the right to appeal.
5. PA authorization period: Most Cigna ADHD PA approvals are valid for 12 months. Your provider will need to resubmit at renewal.

Appealing a Cigna ADHD Prior Authorization Denial in Maine

A PA denial is not the end of the road. Maine members have robust appeal rights:

1. Peer-to-peer review. Your provider can request a phone call with Cigna’s medical reviewer to discuss the clinical rationale. This often resolves denials before a formal appeal is needed.
2. Formal internal appeal. Submit a written appeal with supporting clinical documentation. Maine law requires Cigna to respond within 30 days (non-urgent) or 72 hours (urgent/concurrent). Include office notes, prior treatment history, and a letter of medical necessity.
3. Step therapy exception (if applicable). If Cigna requires a step therapy trial of a medication that is clinically inappropriate, contraindicated, or has previously failed, Maine law provides a right to a step therapy exception. Your provider can request this in writing; Cigna must respond within 72 hours (urgent) or 5 business days (non-urgent).
4. Parity complaint under § 2749-A. If Cigna is applying more restrictive PA requirements to ADHD medication than to comparable medical/surgical drugs, you may file a parity complaint with the Maine Bureau of Insurance at 1-800-300-5000.
5. External independent medical review (IMR). If the internal appeal is denied, Maine members may request an external IMR through the Maine Bureau of Insurance. An independent, certified reviewer makes a final binding decision.

Getting ADHD Treatment Through Klarity Health with Cigna in Maine

Klarity Health is a telehealth platform with 2,000+ licensed providers offering ADHD evaluations, diagnosis, and ongoing medication management across Maine. Klarity’s providers are EPCS-capable. Meaning they can electronically prescribe Schedule II stimulants directly to your Maine pharmacy, fully compliant with Maine’s EPCS mandate.

Klarity’s team can also assist with Cigna prior authorization submission. Because all stimulants now require PA under Cigna’s IP0477 policy, having a provider experienced with the PA process is especially valuable.

Check if your Cigna plan may cover ADHD treatment at Klarity Health →

Frequently Asked Questions

Does Cigna cover ADHD evaluations in Maine?

Cigna plans may cover ADHD evaluations performed by in-network licensed providers, including psychiatrists, psychologists, and APRNs. Coverage is subject to your plan’s deductible, copay, and prior authorization requirements. Verify with Cigna at 1-800-244-6224 before booking.

Does Cigna require prior authorization for generic Adderall in Maine?

Yes. Under Cigna’s IP0477 policy (effective May 15, 2026), all ADHD stimulants. Including generic amphetamine salts. Require prior authorization through Express Scripts. This applies to both generic and brand medications.

Can I get an ADHD stimulant prescription via telehealth in Maine?

Yes. Telehealth providers licensed in Maine and registered with the DEA can prescribe Schedule II stimulants electronically, in compliance with Maine’s EPCS mandate. Platforms like Klarity Health are EPCS-capable.

What if I can’t tolerate stimulants?

Non-stimulant ADHD medications. Including Strattera (atomoxetine), Qelbree (viloxazine), Intuniv (guanfacine ER), and Kapvay (clonidine ER). Are non-scheduled and not subject to Maine’s EPCS requirement. They may still require prior authorization under Cigna’s ESI formulary, but are a valid option for patients who cannot tolerate or have contraindications to stimulants.

What is Maine’s mental health parity law for ADHD?

Me. Rev. Stat. Ann. tit. 24-A, § 2749-A requires Cigna to cover ADHD treatment (mental health benefits) on terms no more restrictive than comparable medical/surgical benefits. If you believe parity is being violated, contact the Maine Bureau of Insurance at 1-800-300-5000.

How do I appeal a Cigna ADHD medication denial in Maine?

Start with a peer-to-peer review request from your provider. If that does not resolve the denial, file a formal internal appeal with clinical documentation. If the internal appeal fails, request an external independent medical review through the Maine Bureau of Insurance.

Key Contacts

• Cigna Member Services: 1-800-244-6224
• Express Scripts (ESI) Pharmacy: 1-800-835-3784
• Maine Bureau of Insurance: 1-800-300-5000
• DOL Employee Benefits Security Administration (EBSA): 1-866-444-3272
• CMS Medicare/Medicaid: 1-800-633-4227

Coverage disclaimer: This article is for informational purposes only and does not constitute insurance advice. Coverage for ADHD treatment varies by Cigna plan, employer group contract, and individual benefit design. Always verify your specific benefits with Cigna before scheduling or filling a prescription. Klarity Health is not affiliated with Cigna or Express Scripts.